5(6)-CFDA

CAS No. 124387-19-5

5(6)-CFDA( 5-(6)-Carboxyfluorescein diacetate | CFDA )

Catalog No. M23417 CAS No. 124387-19-5

5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
25MG 31 In Stock
50MG 44 In Stock
100MG 74 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5(6)-CFDA
  • Note
    Research use only, not for human use.
  • Brief Description
    5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activities.
  • Description
    5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activities, which is required to activate its fluorescence, and cell-membrane integrity, which is required for intracellular retention of their fluorescent product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-(6)-Carboxyfluorescein diacetate | CFDA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    124387-19-5
  • Formula Weight
    920.78
  • Molecular Formula
    C50H32O18
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:120 mg/mL (260.65 mM)
  • SMILES
    CC(OC1=CC=C2C(OC3=C(C=CC(OC(C)=O)=C3)C24C5=CC(C(O)=O)=CC=C5C(O4)=O)=C1)=O.CC(OC6=CC=C7C(OC8=C(C=CC(OC(C)=O)=C8)C79C%10=CC=C(C(O)=O)C=C%10C(O9)=O)=C6)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang T, et al. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia. Immunobiology. 2013 Apr;218(4):548-53.
molnova catalog
related products
  • MW01-2-151SRM

    MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.

  • Fluridone

    Fluridone (EL-171) is a potent inhibitor of abscisic acid (ABA) synthesis, inhibits the expression of AchnFAR and TF genes, and reduces the formation of primary alcohol.

  • Oxelumab

    Oxelumab (R 4930) is a human monoclonal antibody targeting OX40L, and could be used to study asthma.